1. Home
  2. PROK vs PNBK Comparison

PROK vs PNBK Comparison

Compare PROK & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • PNBK
  • Stock Information
  • Founded
  • PROK 2015
  • PNBK 1999
  • Country
  • PROK United States
  • PNBK United States
  • Employees
  • PROK N/A
  • PNBK N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • PNBK Major Banks
  • Sector
  • PROK Health Care
  • PNBK Finance
  • Exchange
  • PROK Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • PROK 85.5M
  • PNBK 84.4M
  • IPO Year
  • PROK N/A
  • PNBK N/A
  • Fundamental
  • Price
  • PROK $3.27
  • PNBK $1.41
  • Analyst Decision
  • PROK Buy
  • PNBK
  • Analyst Count
  • PROK 5
  • PNBK 0
  • Target Price
  • PROK $6.25
  • PNBK N/A
  • AVG Volume (30 Days)
  • PROK 37.1M
  • PNBK 1.1M
  • Earning Date
  • PROK 08-08-2025
  • PNBK 08-08-2025
  • Dividend Yield
  • PROK N/A
  • PNBK N/A
  • EPS Growth
  • PROK N/A
  • PNBK N/A
  • EPS
  • PROK N/A
  • PNBK N/A
  • Revenue
  • PROK $306,000.00
  • PNBK $14,940,000.00
  • Revenue This Year
  • PROK $85.21
  • PNBK N/A
  • Revenue Next Year
  • PROK N/A
  • PNBK N/A
  • P/E Ratio
  • PROK N/A
  • PNBK N/A
  • Revenue Growth
  • PROK N/A
  • PNBK N/A
  • 52 Week Low
  • PROK $0.46
  • PNBK $0.90
  • 52 Week High
  • PROK $7.13
  • PNBK $7.47
  • Technical
  • Relative Strength Index (RSI)
  • PROK 62.08
  • PNBK 44.19
  • Support Level
  • PROK $3.17
  • PNBK $1.41
  • Resistance Level
  • PROK $4.05
  • PNBK $1.55
  • Average True Range (ATR)
  • PROK 1.00
  • PNBK 0.10
  • MACD
  • PROK 0.13
  • PNBK 0.08
  • Stochastic Oscillator
  • PROK 43.10
  • PNBK 65.80

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: